臨床前醫療設備測試服務市場規模、佔有率、趨勢分析報告：按服務、按地區、細分市場預測，2025-2030 年

臨床前醫療設備測試服務市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球臨床前醫療設備檢測服務市場規模將達到65.5億美元，複合年成長率為9.20%。

疾病的日益普及為製造商提供了不同的醫療設備形成方法，對技術先進的醫療設備的需求不斷增加是推動市場成長的主要因素。

近年來，醫療保健產業的技術進步步伐顯著加快。醫療設備技術的進步支持疾病管理中更簡單、更少痛苦的治療。此外，醫療設備技術的進步不僅有助於準確、快速的疾病診斷結果，而且還有助於提高基於技術的疾病治療工具的可負擔性。此外，許多政府機構和醫療保健組織也支持醫學研究設施。這筆資金主要旨在促進全球醫療創新。因此，醫療設備測試在預期期間的成長得到了不斷擴大的技術創新和技術進步的支持。

臨床前測試在新產品的開發過程中發揮重要作用。大部分測試應該已經完成，並且在人體試驗開始之前應該可以提供報告。根據 ISO-10993，對於直接與患者接觸或與血液供應接觸的 II 類設備，生物相容性測試結果必須包含在 510(k) 信件中。這表明新設備的風險與領先設備的風險「基本上相當」。測試還可以包括動物和台架測試，以證明新設備的效用、檢驗電氣安全或檢查電磁干擾。

COVID-19 為這些服務創造了巨大的需求。上半年成長較為溫和，但下半年成長更為強勁，因為疫情期間產業更快採用了新的規範。許多因新冠疫情而暫停的計劃已恢復，增加了個人防護裝備套件的生產和測試。疫情期間，許多需求旺盛的醫療設備轉移了人們對手術所需設備的注意力。 COVID-19 疫苗、人工呼吸器和脈動式血氧監測儀系統是需求激增的主要產品。

臨床前醫療設備測試服務市場報告亮點

• 2024年，生物相容性測試領域佔據市場主導地位，佔45.06%的收益佔有率。此測試是醫療設備開發的關鍵步驟，生物相容性評估提供的資料醫療設備製造商可用於確保患者的器材安全並支援法規遵循很有幫助。
• 化學測試產業預計複合年成長率最快，達 9.63%。進行此測試的目的是對醫療設備製造中使用的化學品進行分類、識別和理解。
• 由於醫療設備測試服務的外包成本較低，預計亞太地區將在 2024 年引領全球市場，在預測期內複合年成長率最快，達到 9.47%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章臨床前醫療設備測試服務市場變數、趨勢與範圍

• 市場體系展望
  • 母市場展望
  • 相關/附隨市場展望
• 市場動態
  • 市場推動要素分析
  • 市場限制因素分析
• 市場分析工具
  • 波特五力分析
  • PESTEL分析
  • COVID-19 影響分析

第4章臨床前醫療設備檢測服務市場：服務評估與趨勢分析

• 細分儀表板
• 全球臨床前醫療設備測試服務市場；方法學變異分析；
• 2018-2030年全球臨床前醫療設備檢測服務規模及趨勢分析（分方法）
• 生物相容性測試
• 化學測試
• 微生物學和無菌測試
  • 微生物附著量測量
  • 熱原和內毒素檢測
  • 無菌測試和檢驗
  • 抗菌活性測試
  • 其他
• 包裹檢驗

第5章臨床前醫療設備測試服務市場：區域估計與趨勢分析

• 2024 年及 2030 年區域市場佔有率分析
• 區域市場儀表板
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 丹麥
  • 瑞典
  • 挪威
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 韓國
  • 泰國
• 拉丁美洲
  • 巴西
  • 阿根廷
• 中東/非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 科威特

第6章 競爭狀況

• 公司分類
• 2024 年企業市場分析
• 公司簡介
  • SGS SA
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group Plc
  • WUXI APPTEC
  • TUV SUD AG
  • Sterigenics International LLC
  • Nelson Labs
  • North American Science Associates, Inc.
  • Charles River Laboratories International, Inc.

Preclinical Medical Device Testing Services Market Growth & Trends:

The global preclinical medical device testing services market size is expected to reach USD 6.55 billion by 2030, registering a CAGR of 9.20%, according to a new report by Grand View Research, Inc. The rising incidence of diseases has provided manufacturers with different approaches for the formation of medical devices and increasing demand for technologically advanced medical devices are the main factors driving the market growth.

The pace of technological advancement in the healthcare industry has vastly increased in recent years. Medical device technology advancements support simple, painless treatment during disease management. Additionally, advancements in medical device technology help with accurate and quick disease diagnosis results, as well as the affordability of technology-based therapeutic tools for disease treatment. Furthermore, numerous governmental agencies and healthcare institutions support medical research facilities. This funding is primarily intended to promote global health care innovations. The growth of medical device testing in the anticipated period is therefore supported by expanding innovation and technological advancement.

Preclinical testing plays a crucial role in the process of creating new products. Before beginning human testing, most of this testing has been completed and reports should be available. According to ISO-10993, biocompatibility testing results are needed to be included in 510(k) notifications for Class II equipment that has immediate patient contact or contact with the blood supply. This shows that the new device's risks are "substantially equivalent" to the predicate device's risks. In order to show the utility of the new device, validate electrical safety, or examine electromagnetic interference, the testing also involves animal and bench studies.

COVID-19 has created an enormous demand for these services. The growth was not significant during the first half, but it became more significant during the second as the industry adopted the new norms at a faster pace amid the pandemic. Numerous projects that were halted because of COVID have been restarted and PPE kits are witnessing an increase in production and testing. During the pandemic, many medical devices in high demand diverted attention from the equipment needed for surgery. The COVID-19 vaccines, ventilators, and pulse oximeters are the main products that witnessed a spike in demand.

Preclinical Medical Device Testing Services Market Report Highlights:

• In 2024, the biocompatibility tests segment dominated the market, accounting for a revenue share of 45.06%. The test is a critical step for medical device development where an assessment of biocompatibility helps medical device manufacturers ensure the device's safety for patients & provides data that can be used to support regulatory compliance.
• The chemistry test segment is anticipated to exhibit the fastest CAGR of 9.63%. The test is conducted in order to categorize, recognize, and understand the chemicals used in the production of medical devices
• Asia Pacific led the global market in 2024 and is projected to witness the fastest CAGR of 9.47% during the forecast years due to the low cost of outsourcing medical device testing services

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis
  • 1.6.2. Bottom-up Approach
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Preclinical Medical Device Testing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Complexity in product design
    • 3.2.1.2. Strict approval norms
    • 3.2.1.3. Increase in number of small medical device lacking in-house testing capabilities
    • 3.2.1.4. Intense competition in medical device industry
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Legal and Regulatory Issues
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Preclinical Medical Device Testing Services Market: Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Preclinical Medical Device Testing Services Market; Method Movement Analysis
• 4.3. Global Preclinical Medical Device Testing Services Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
• 4.4. Biocompatibility Tests
  • 4.4.1. Biocompatibility tests market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Chemistry Test
  • 4.5.1. Chemistry test market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Microbiology & Sterility Testing
  • 4.6.1. Microbiology & sterility testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Bioburden Determination
    • 4.6.2.1. Bioburden determination market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Pyrogen & Endotoxin Testing
    • 4.6.3.1. Pyrogen & endotoxin testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Sterility Test and Validation
    • 4.6.4.1. Sterility test and validation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.2. Ethylene Oxide (EO) gas sterilization
      • 4.6.4.2.1. Ethylene oxide (EO) gas sterilization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.3. Gamma-irradiation
      • 4.6.4.3.1. Gamma-irradiation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.4. E-beam sterilization
      • 4.6.4.4.1. E-beam sterilization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.5. X-ray sterilization
      • 4.6.4.5.1. X-ray sterilization market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.5. Antimicrobial Activity Testing
    • 4.6.5.1. Antimicrobial activity testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Package Validation
  • 4.7.1. Package validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Preclinical Medical Device Testing Services Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. North America
  • 5.3.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Competitive scenario
    • 5.3.2.3. Regulatory framework
    • 5.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Key country dynamics
    • 5.3.3.2. Competitive scenario
    • 5.3.3.3. Regulatory framework
    • 5.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Mexico
    • 5.3.4.1. Key country dynamics
    • 5.3.4.2. Competitive scenario
    • 5.3.4.3. Regulatory framework
    • 5.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. UK
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Competitive scenario
    • 5.4.2.3. Regulatory framework
    • 5.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Germany
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Competitive scenario
    • 5.4.3.3. Regulatory framework
    • 5.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. France
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Competitive scenario
    • 5.4.4.3. Regulatory framework
    • 5.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Italy
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Competitive scenario
    • 5.4.5.3. Regulatory framework
    • 5.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Spain
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Competitive scenario
    • 5.4.6.3. Regulatory framework
    • 5.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Denmark
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Competitive scenario
    • 5.4.7.3. Regulatory framework
    • 5.4.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.8. Sweden
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Competitive scenario
    • 5.4.8.3. Regulatory framework
    • 5.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.9. Norway
    • 5.4.9.1. Key country dynamics
    • 5.4.9.2. Competitive scenario
    • 5.4.9.3. Regulatory framework
    • 5.4.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5.2. Japan
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Competitive scenario
    • 5.5.2.3. Regulatory framework
    • 5.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.3. China
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Competitive scenario
    • 5.5.3.3. Regulatory framework
    • 5.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.4. India
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Competitive scenario
    • 5.5.4.3. Regulatory framework
    • 5.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.5. Australia
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Competitive scenario
    • 5.5.5.3. Regulatory framework
    • 5.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.6. South Korea
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Competitive scenario
    • 5.5.6.3. Regulatory framework
    • 5.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.7. Thailand
    • 5.5.7.1. Key country dynamics
    • 5.5.7.2. Competitive scenario
    • 5.5.7.3. Regulatory framework
    • 5.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Latin America
  • 5.6.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6.2. Brazil
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Competitive scenario
    • 5.6.2.3. Regulatory framework
    • 5.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.3. Argentina
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Competitive scenario
    • 5.6.3.3. Regulatory framework
    • 5.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. MEA
  • 5.7.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7.2. South Africa
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Competitive scenario
    • 5.7.2.3. Regulatory framework
    • 5.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.3. Saudi Arabia
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Competitive scenario
    • 5.7.3.3. Regulatory framework
    • 5.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.4. UAE
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Competitive scenario
    • 5.7.4.3. Regulatory framework
    • 5.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.5. Kuwait
    • 5.7.5.1. Key country dynamics
    • 5.7.5.2. Competitive scenario
    • 5.7.5.3. Regulatory framework
    • 5.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Company Market Position Analysis, 2024
• 6.3. Company Profiles
  • 6.3.1. SGS SA
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Service benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. Eurofins Scientific
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Service benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Pace Analytical Services LLC
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Service benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Intertek Group Plc
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Service benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. WUXI APPTEC
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Service benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. TUV SUD AG
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Service benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Sterigenics International LLC
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Service benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Nelson Labs
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Service benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. North American Science Associates, Inc.
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Service benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Charles River Laboratories International, Inc.
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Service benchmarking
    • 6.3.10.4. Strategic initiatives

List of Tables

• Table 1. List of Tables
• Table 2. List of Secondary Sources
• Table 3. List of Abbreviations
• Table 4. Global Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 5. Global Preclinical Medical Device Testing Services Market, by Region, 2018 - 2030 (USD Million)
• Table 6. North America Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 7. North America Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 8. U.S. Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 9. Canada Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 10. Mexico Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 11. Europe Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 12. Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 13. UK Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 14. Germany Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 15. France Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 16. Italy Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 17. Spain Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 18. Denmark Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 19. Sweden Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 20. Norway Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 21. Asia Pacific Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 22. Asia Pacific Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 23. Japan Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 24. China Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 25. India Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 26. Thailand Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 27. South Korea Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 28. Australia Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 29. Latin America Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 30. Latin America Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 31. Brazil Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 32. Argentina Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 33. Middle East & Africa Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 34. Middle East & Africa Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 35. South Africa Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 36. Saudi Arabia Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 37. UAE Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 38. Kuwait Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for Market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Preclinical Medical Device Testing Services Market revenue, 2018 - 2030 (USD Million)
• Fig. 10 Preclinical Medical Device Testing Services Market snapshot
• Fig. 11 Preclinical Medical Device Testing Services Market driver impact
• Fig. 12 Preclinical Medical Device Testing Services Market restraint impact
• Fig. 13 Preclinical Medical Device Testing Services Market: Service takeaways (USD Million)
• Fig. 14 Preclinical Medical Device Testing Services Market: Service movement analysis
• Fig. 15 Biocompatibility Tests Market, 2018 - 2030 (USD Million)
• Fig. 16 Chemistry Test Market, 2018 - 2030 (USD Million)
• Fig. 17 Microbiology & Sterility Testing Market, 2018 - 2030 (USD Million)
• Fig. 18 Bioburden Determination Market, 2018 - 2030 (USD Million)
• Fig. 19 Pyrogen & Endotoxin Testing Market, 2018 - 2030 (USD Million)
• Fig. 20 Sterility Test and Validation Market, 2018 - 2030 (USD Million)
• Fig. 21 Ethylene Oxide (EO) gas sterilization Market, 2018 - 2030 (USD Million)
• Fig. 22 Gamma-irradiation Market, 2018 - 2030 (USD Million)
• Fig. 23 E-beam sterilization Market, 2018 - 2030 (USD Million)
• Fig. 24 X-ray sterilization Market, 2018 - 2030 (USD Million)
• Fig. 25 Antimicrobial Activity Testing Market, 2018 - 2030 (USD Million)
• Fig. 26 Others Market, 2018 - 2030 (USD Million)
• Fig. 27 Package Validation Market, 2018 - 2030 (USD Million)
• Fig. 28 Regional Marketplace: Key takeaways
• Fig. 29 Regional outlook, 2024 & 2030
• Fig. 30 North America Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 32 Canada Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 33 Mexico Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 34 Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 35 UK Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 36 Germany Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 37 France Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 38 Italy Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 39 Spain companion animal Health Market, 2018 - 2030 (USD Million)
• Fig. 40 Sweden Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 41 Denmark Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 42 Norway Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 43 Asia Pacific Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 44 Japan Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 45 China Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 46 India Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 47 Thailand Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 48 South Korea Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 49 Australia Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 52 Argentina Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 53 Middle East & Africa Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 54 South Africa Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 55 Saudi Arabia Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 56 UAE Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 57 Kuwait Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 58 Market participant categorization